Clinical endocannabinoid deficiency (CECD): Can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions? (PubMed)
Effects of anandamide in migraine: data from an animal model (PubMed)
Cannabinoids and hallucinogens for headache (PubMed)
The endocannabinoid system and migraine (PubMed)
Variations in the cannabinoid receptor 1 gene predispose to migraine (PubMed)
© 2020 Sciva Corporation s.r.o. All Rights Reserved.